The UK will review its NHS contract with US software firm Palantir
Key takeaways
- A recent government report called Palentir's presence an "unacceptable point of weakness."
- DIA TV/Shutterstock The UK government is reviewing its National Health Service (NHS) partnership with US data firm Palantir to decide if it will end the contract early, Reuters reported.
- Technology minister Liz Kendall said the review would evaluate the NHS's £330 million ($441 million) deal with Palentir and decide whether to terminate it using a "break clause" at the end of the initial term in 2027.
A recent government report called Palentir's presence an "unacceptable point of weakness."
DIA TV/Shutterstock The UK government is reviewing its National Health Service (NHS) partnership with US data firm Palantir to decide if it will end the contract early, Reuters reported. The decision follows the release of a parliamentary committee report that called Palantir's increasing presence in the UK public sector an "unacceptable point of weakness."
Technology minister Liz Kendall said the review would evaluate the NHS's £330 million ($441 million) deal with Palentir and decide whether to terminate it using a "break clause" at the end of the initial term in 2027. "The current health secretary is reviewing every single aspect of that (contract) to make sure we get the right deal for Britain," Kendall told Times Radio.